Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

lixisenatide MeSH Supplementary Concept Data 2025


MeSH Supplementary
lixisenatide
Unique ID
C479460
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C479460
Entry Term(s)
AQVE-10010
AVE 0010
AVE 010
AVE-0010
AVE-010
AVE0010
Adlyxin
DES-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-l-lysyl-l-lysinamide
Lyxumia
ZP 10
ZP-10
ZP10A peptide
Registry Numbers
74O62BB01U
0
Previous Indexing
*CARRIER PROTEINS (2003-2010)
Heading Mapped to
*Peptides
*Glucagon-Like Peptide-2 Receptor
Frequency
255
Note
A synthetic GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1) agonist that binds GLP-1 receptor that is used to control blood sugar levels in patients with TYPE 2 DIABETES; amino acid sequence is H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSK KKKKK-NH2 (ZP10A).
Source
J Pharmacol Exp Ther 2003 Nov;307(2);490-6
Indexing Information
Glucagon-Like Peptide-1 Receptor
Date of Entry
2003/12/08
Revision Date
2023/05/31
lixisenatide Preferred
AVE 0010 Narrower
AQVE-10010 Narrower
Lyxumia Narrower
Adlyxin Narrower
AVE 010 Narrower
ZP10A peptide Narrower
ZP 10 Narrower
page delivered in 0.004s